Adriamycin/5-Flurouracil 치료 중인 유방암 환자의 한･양방 병용치료를 통한 부작용 경감에 대한 증례보고
Case Report of a Breast Cancer Patient Treated with Adriamycin/5-Fluriuracil Regimen in Combination with Traditional Korean Medicine for Mitigating Side Effects
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives : To observe the mitigating effects of a Traditional Korean Medicine treatment program, called Wheel Balanced Cancer Therapy (WBCT), with Adriamycin and 5-FU chemotherapy on a breast cancer patient. Methods : A 26 year old female patient diagnosed with stage IIb breast cancer was admitted to the East-West Cancer Center (EWCC) in February of 2010. She received Adriamycin and 5-FU from February 22nd, to July 20th, 2010 followed by WBCT consisting of herbal medicine, acupuncture, moxibustion and physiotherapy for 5 months. Her symptoms were measured by Common Terminology Criteria for Adverse Events (CTCAE) and her quality of life was measured by Eastern Cooperative Oncology Group (ECOG). Results : WBCT significantly alleviated chemotherapy-induced nausea, oral dryness, and peripheral neuropathy. Quality of life also significantly improved. Conclusions : This case study potentiates WBCT's significant efficacy in aiding breast cancer patients suffering from Adriamycin plus 5-FU chemotherapy induced adverse effects.
Abstract
Objectives : To observe the mitigating effects of a Traditional Korean Medicine treatment program, called Wheel Balanced Cancer Therapy (WBCT), with Adriamycin and 5-FU chemotherapy on a breast cancer patient. Methods : A 26 year old female patient diagnosed with stage IIb breast cancer was admitted to the East-West Cancer Center (EWCC) in February of 2010. She received Adriamycin and 5-FU from February 22nd, to July 20th, 2010 followed by WBCT consisting of herbal medicine, acupuncture, moxibustion and physiotherapy for 5 months. Her symptoms were measured by Common Terminology Criteria for Adverse Events (CTCAE) and her quality of life was measured by Eastern Cooperative Oncology Group (ECOG). Results : WBCT significantly alleviated chemotherapy-induced nausea, oral dryness, and peripheral neuropathy. Quality of life also significantly improved. Conclusions : This case study potentiates WBCT's significant efficacy in aiding breast cancer patients suffering from Adriamycin plus 5-FU chemotherapy induced adverse effects.
참고문헌 (12)
- "2008년 국가암등록통계" (2010), 보건복지부 중앙암등록본부[URL]
- 정경해, "진행성 유방암의 맞춤 항암요법의 최신 지견", 대한내과학회지, 77(1), pp.26~34 (2009), 대한내과학회
- Berry DA, "Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer", N Engl J Med, 353(17), pp.1784~1792 (2005)
- Dodd MJ, "Symptom clusters and their effect on the functional status of patients with cancer", Oncol Nurs Forum, 28(3), pp.465~470 (2001)
- Lee HY, "Prevention and treatment of postoperative nausea and vomiting", J Korean Med Assoc, 50(1), pp.65~70 (2007)
- Jacobson JS, "Research on complementary", alternative medicine for breast cancer : A review of the biomedical literature, 2000, pp.18(3), 668~683
- Zheng HM, "Evidence Based Approach of Wheel Balance Cancer Therapy; A Review", 석사, pp.2011
- Park HM, "Integrative Tumor Board: A Case Report and Discussion From East-West Cancer Center", INTEGRATIVE CANCER THERAPIES, 9(2), pp.236~245 (2010), INTEGRATIVE CANCER THERAPIES
- Giantonio BJ, "The role of the Eastern Cooperative Oncology Group in establishing standards of cancer care: over 50 years of progress through clinical research", Semin Oncol, 35(5), pp.494~506 (2008)
- Hassan BA, "Negative impact of chemotherapy on breast cancer patients QOL - utility of antiemetic treatment guidelines and the role of race", Asian Pac J Cancer Prev, 11(6), pp.1523~1527 (2010)
- 문병인, "조기 유방암 환자에서 CMF 항암제와 방사선 동시 치료의 독성", Journal of Breast Cancer, 10(2), pp.147~152 (2007), 한국유방암학회
- 우희두, "한국 유방암 환자에서 TAC 보조항암화학요법의 독성 및 내성에 대한 연구", Journal of Breast Cancer, 14, pp.44~49 (2011), 한국유방암학회